悬赏20积分
DOI号:10.1016/j.ejca.2025.115808
文献链接:https://pubmed.ncbi.nlm.nih.gov/41005213/
文献作者:
Chunmei Bai 1, Yi Zheng 2, Meili Sun 3, Jieer Ying 4, Fuxiang Zhou 5, Yiyi Yu 6, Ligang Xing 7, Yanqiao Zhang 8, Jinhua Wen 9, Heshui Wu 10, Xiuli Yang 11, Lixin Wan 12, Shiwei Guo 13, Rusen Zhao 14, Zhizhen Zhu 15, Wei Shen 16, Qi Wang 17, Shanzhi Gu 18, Hao Wu 19, Weichang Chen 20, Jin Xia 21, Jun Zhao 22, Xiaofang Dong 23, Wenhui Lou 24, Kuirong Jiang 19, Zhiye Zhang 25, Xiaobing Chen 26, Deliang Fu 27, Youshan Chen 28, Baoqing Wang 29, Jiaxin Liu 30, Yuan Ji 31, Shijie Yuan 32, Yuan Li 33, Zhihua Gong 33, Da Fei 33, Xia Qin 33, Crystal Qin 33, Jin Li 34
备注信息:Tecotabart vedotin in Claudin 18.2-positive advanced gastric/gastroesophageal junction cancer: A Bayesian phase 1/2 clinical trial |
|
求助已关闭
30
